Thai Plaspac PCL

Thai Plaspac maintains a capital structure with a debt-to-equity ratio of 1.07, indicating a moderate reliance on debt financing. The company's liquidity position is constrained, with a current ratio of 0.96 and negligible cash and equivalents of THB 480 million. This suggests limited short-term liquidity to cover immediate obligations, particularly given the THB 3.1 billion in long-term debt. Profitability metrics show a return on equity (ROE) of 16.44% and a return on assets (ROA) of 6.51%, which are strong relative to the industry median of 12.0% ROE and 5.0% ROA. The company's operating margin of 11.38% (calculated from operating income of THB 775.9 million on revenue of THB 6.8 billion) is also above the industry median of 9.0%. These metrics suggest efficient operations and strong pricing power in its core markets. Geographically, Thai Plaspac operates in Thailand and has expansion into India, UAE, Malaysia, and the Philippines. Revenue concentration is primarily in Thailand, with overseas operations contributing a smaller but growing portion. The company's exposure to Southeast Asia and South Asia aligns with regional demand for FMCG and pharmaceutical packaging, though it remains vulnerable to local economic fluctuations. Growth trajectory is positive, with a price-to-earnings (P/E) ratio of 5.92 and a price-to-book (P/B) ratio of 0.97, both below the industry median of 7.5 and 1.2, respectively. The company's free cash flow of THB 444.3 million supports reinvestment and shareholder returns. Outlook for the current fiscal year indicates a 5.0% revenue increase, driven by expansion in India and Malaysia. Risk factors include medium liquidity risk due to low cash reserves and high debt levels. The company's dilution risk is low, with no significant dilution sources identified in recent filings. However, the net cash position is negative after subtracting total debt, signaling potential refinancing needs. Recent events include the expansion of operations in India and the Philippines, with new facilities expected to contribute to revenue growth in the next fiscal year. The company has also invested in the SUNPET brand for common mold products, which is expected to diversify its product portfolio and reduce dependency on core FMCG packaging.